Werewolf Therapeutics, Inc.
HOWL
$0.8907
-$0.0064-0.71%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -88.70% | -66.56% | -31.20% | 17.58% | 30.56% |
| Total Depreciation and Amortization | 2.83% | 6.45% | 8.51% | 26.00% | 59.78% |
| Total Amortization of Deferred Charges | -- | -100.00% | -100.00% | -100.00% | -70.44% |
| Total Other Non-Cash Items | 13.15% | 8.64% | 17.33% | 17.14% | -5.79% |
| Change in Net Operating Assets | 142.86% | 130.48% | 104.76% | -337.50% | -332.14% |
| Cash from Operations | -72.29% | -16.60% | 12.50% | -4.02% | 19.67% |
| Capital Expenditure | 66.97% | 69.79% | 80.62% | 81.02% | 78.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 66.97% | 69.79% | 80.62% | 81.02% | 78.70% |
| Total Debt Issued | -25.00% | -25.00% | -25.00% | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 28.92% | 192.35% | 41.08% | 22.93% | 15.22% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -366.01% | -545.70% | -- | -- |
| Cash from Financing | -77.61% | -61.26% | -68.12% | -53.29% | 267.34% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -273.12% | -383.03% | -289.99% | -135.96% | 188.51% |